Results
Kwality Pharma Q4 Revenue Up 35.8% to ₹157.1 Crore
Kwality Pharmaceuticals reported Q4FY26 revenue growth of 35.8% to ₹157.1 crore and full-year revenue of ₹503 crore, up 36% YoY.
PAT grew 69% to ₹67 crore for FY26 with EBITDA margins expanding from 2
